000 01576 a2200421 4500
005 20250513183940.0
264 0 _c19990707
008 199907s 0 0 eng d
022 _a0091-6749
024 7 _a10.1016/s0091-6749(99)70178-8
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCockcroft, D W
245 0 0 _aTolerance to the bronchoprotective effect of beta2-agonists: comparison of the enantiomers of salbutamol with racemic salbutamol and placebo.
_h[electronic resource]
260 _bThe Journal of allergy and clinical immunology
_cJun 1999
300 _a1049-53 p.
_bdigital
500 _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAdrenergic beta-Agonists
_xpharmacology
650 0 4 _aAdult
650 0 4 _aAlbuterol
_xpharmacology
650 0 4 _aBronchi
_xdrug effects
650 0 4 _aBronchial Provocation Tests
650 0 4 _aBronchoconstriction
_xdrug effects
650 0 4 _aBronchodilator Agents
_xpharmacology
650 0 4 _aCross-Over Studies
650 0 4 _aDouble-Blind Method
650 0 4 _aDrug Tolerance
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPlacebos
650 0 4 _aStereoisomerism
700 1 _aDavis, B E
700 1 _aSwystun, V A
700 1 _aMarciniuk, D D
773 0 _tThe Journal of allergy and clinical immunology
_gvol. 103
_gno. 6
_gp. 1049-53
856 4 0 _uhttps://doi.org/10.1016/s0091-6749(99)70178-8
_zAvailable from publisher's website
999 _c10318469
_d10318469